摘要
目的观察多巴胺D3受体对醛固酮介导的血管平滑肌细胞(vascular smooth muscle cells,VSMCs)增殖的影响。方法以大鼠胸主动脉平滑肌细胞株(A10细胞)为研究对象,观察在醛固酮10-10~10-7mol/L、多巴胺D3受体激动剂(PD128907)10-10~10-7mol/L分别单独作用,醛固酮10-7mol/L、PD128907 10-10~10-7mol/L共同作用以及D3受体拮抗剂(U99194A)、PD128907 10-7mol/L和醛固酮10-7mol/L共同作用的情况下,A10细胞增殖幅度的变化,细胞增殖用3H-胸腺嘧啶核苷掺入法测定。Western blot检测ERK1/2、p-ERK1/2表达。结果醛固酮呈浓度依赖性地促进A10细胞的增殖,其最大促增殖作用幅度达(65±6)%(P<0.05)。PD128907本身对A10细胞增殖无影响,但PD128907可通过D3多巴胺受体减弱醛固酮(10-7mol/L)介导的A10细胞增殖,在10-7mol/L浓度时可使促增殖幅度降低至(12±6)%(P<0.05),应用D3受体阻断剂U99194A后该抑制作用丧失。PD128907能够降低醛固酮(10-7mol/L)对ERK1/2信号的磷酸化激活效果。结论多巴胺D3受体激活对醛固酮介导的促VSMCs增殖有明显抑制效应。
Objective To investigate the effect of D3 dopamine receptor on aldosterone-induced proliferation of vascular smooth muscle cells (VSMCs). Methods A10 cells (rat aortic vascular smooth muscle cells) were incubated with different concentrations of aldosterone from 10-10 to 10-7 mol/L in presence or absence of D3 dopamine receptor agonist PD128907 (10-10 to 10-7) and antagonist U99194A. The proliferation of VSMCs was determined by [3H]-TdR incorporation. The expression of ERK1/2, p-ERK1/2 were detected by Western blotting. Results Aldosterone treatment resulted in an increased proliferation of VSMCs in a dose-dependent manner with a maximal proliferative amplitude of (65±6)% (P〈0.05). Although D3 dopamine receptor agonists PD128907 had no effect on the proliferation of VSMCs by itself, it effectively blocked the aldosterone-mediated proliferation of VSMCs and lowered the proliferative amplitude to (12±6)% (P〈0.05), probably through ERK1/2 pathway. Conclusion Activation of D3 receptor inhibits aldosterone-mediated proliferation of VSMCs.
出处
《第三军医大学学报》
CAS
CSCD
北大核心
2013年第10期943-946,共4页
Journal of Third Military Medical University
基金
国家重点基础研究发展计划(973计划,2012CB17801)
国家自然科学基金重点项目(31130029)
国家杰出青年科学基金(30925018)~~
关键词
多巴胺受体
醛固酮
血管平滑肌细胞
细胞增殖
D3 dopamine receptor
aldosterone
vascular smooth muscle cells
cell proliferation